Kapil Dhingra's Net Worth

$1.75 Million

Estimate Recalculated Sep 8, 2024 07:31PM EST

Who is Kapil Dhingra?

Kapil Dhingra has an estimated net worth of $1.75 Million. This is based on reported shares across multiple companies, which include Replimune Group, Inc., Black Diamond Therapeutics, Inc., MICROMET, INC., FIVE PRIME THERAPEUTICS, INC., and CARGO Therapeutics, Inc..

SEC CIK

Kapil Dhingra's CIK is 0001456849

Past Insider Trading and Trends

2024 was Kapil Dhingra's most active year for acquiring shares with 4 total transactions. Kapil Dhingra's most active month to acquire stocks was the month of May. 2021 was Kapil Dhingra's most active year for disposing of shares, totalling 5 transactions. Kapil Dhingra's most active month to dispose stocks was the month of March. 2020 saw Kapil Dhingra paying a total of $70,000.00 for 76,500 shares, this is the most they've acquired in one year. In 2020 Kapil Dhingra cashed out on 80,000 shares for a total of $1,822,394.89, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Replimune Group, Inc. (REPL) Snapshot price: $10.88

Investor

Kapil Dhingra used to own units in Common Stock but no longer holds any shares there. From 2018 to 2024 Kapil Dhingra acquired a total of 40,000 shares in Replimune Group, Inc. at a cost of $70,000.00, Kapil also disposed a total of 40,000 shares of Replimune Group, Inc. equalling to $1,822,394.89.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
$23.66
-$1,752,394.89
0
Dec 7
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Jul 24
Form 3
—
0
—
—
0
No matching records found

Black Diamond Therapeutics, Inc. (BDTX) Snapshot price: $5.4

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
May 16
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
Jan 19
Form 3
—
0
—
—
0
No matching records found

MICROMET, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Feb 18
Form 3
—
0
—
—
0
No matching records found

FIVE PRIME THERAPEUTICS, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 16
Form 4
—
0
—
—
0
May 14
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
May 10
Form 4
—
0
—
—
0
May 10
Form 4
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
Dec 2
Form 3
—
0
—
—
0
No matching records found

CARGO Therapeutics, Inc. (CRGX) Snapshot price: $18.85

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 4
Form 4
—
0
—
—
0
Apr 15
Form 3
—
0
—
—
0
No matching records found